- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04103736
The Effect of Dietary Nitrates on Physical Performance and Vascular Function in Chronic Kidney Disease
September 24, 2019 updated by: University of Delaware
The purpose of this study is to examine the effect of acute ingestion of a concentrated beetroot juice supplement on vascular function and exercise capacity in patients with moderate to severe chronic kidney disease
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
People with Chronic Kidney Disease (CKD) are at an increased risk of cardiovascular disease.
Blood vessel dysfunction and exercise intolerance are common in CKD.
Blood vessel dysfunction has been shown to predict future cardiovascular events and decreased physical activity can contribute to an increased risk of cardiovascular disease.
Therefore, this study investigates if dietary nitrate from beetroot juice, which has been shown to improve blood vessel function and exercise capacity in other cardiovascular disease pathologies, could be effective at improving these measures in patients with CKD.
In a controlled, double blinded trial, stage 3-5 CKD patients will be randomly assigned to receive either beetroot beverage or a placebo and then complete measures of blood vessel function and an exercise test.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Delaware
-
Newark, Delaware, United States, 19713
- Department of Kinesiology and Applied Physiology, University of Delaware
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
• Stage 3-5 Chronic Kidney Disease
Exclusion Criteria:
- History of cardiovascular disease
- Current pregnancy
- Uncontrolled hypertension
- Uncontrolled hyperlipidemia
- Current hormone replacement therapy
- Current use of tobacco products
- Current autoimmune disease
- Current hyperkalemia
- Diagnosis of a deep vein thrombosis (DVT) within the last 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Beet Juice Supplement
A single, acute dose of Beet It Sport Shot containing ~12.6mmol naturally occurring dietary nitrates.
|
Source of naturally occurring dietary nitrates
|
Placebo Comparator: Placebo juice
A single, acute dose of nitrate-depleted Beet It Sport Shot
|
Placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Microvascular Function, assessed by laser Doppler flowmetry coupled with intradermal microdialysis
Time Frame: 2.5 hours post ingestion of juice
|
Nitric oxide mediated cutaneous microvascular dilatory response to local heating assessed by laser Doppler flowmetry coupled with microdialysis
|
2.5 hours post ingestion of juice
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Endothelial function
Time Frame: 2.5 hours post ingestion of juice
|
Conduit artery endothelial function assessed by brachial artery flow mediated dilation
|
2.5 hours post ingestion of juice
|
Blood pressure
Time Frame: Change from pre-ingestion baseline to 2.5 hours post ingestion of juice
|
Blood pressure recorded by automatic blood pressure machine
|
Change from pre-ingestion baseline to 2.5 hours post ingestion of juice
|
Arterial stiffness
Time Frame: 2.5 hours post ingestion of juice
|
Carotid to femoral pulse wave velocity assessed by tonometry
|
2.5 hours post ingestion of juice
|
Pulse wave analysis
Time Frame: 2.5 hours post ingestion of juice
|
Central blood pressure and augmentation index assessed by oscillometry and radial tonometry
|
2.5 hours post ingestion of juice
|
Peak aerobic capacity
Time Frame: 2.5 hours post ingestion of juice
|
Peak oxygen uptake (VO2 peak) during incremental cycling exercise to exhaustion
|
2.5 hours post ingestion of juice
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2015
Primary Completion (Actual)
June 29, 2017
Study Completion (Actual)
June 29, 2017
Study Registration Dates
First Submitted
April 29, 2019
First Submitted That Met QC Criteria
September 24, 2019
First Posted (Actual)
September 25, 2019
Study Record Updates
Last Update Posted (Actual)
September 25, 2019
Last Update Submitted That Met QC Criteria
September 24, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 706281-6
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endothelial Dysfunction
-
M.D. Anderson Cancer CenterRecruitingEndothelial Dysfunction | Vascular | Endothelial | EndothelixUnited States
-
Clinica ARS MedicaUnknown
-
University of California, San DiegoCompletedEndothelial Dysfunction
-
M.D. Anderson Cancer CenterCompletedEndothelial DysfunctionUnited States
-
NestléCompleted
-
Société des Produits Nestlé (SPN)Completed
-
General Hospital of Chinese Armed Police ForcesChinese PLA General HospitalUnknown
-
University of ConnecticutCompletedEndothelial DysfunctionUnited States
-
Florida State UniversityRecruitingEndothelial DysfunctionUnited States
-
Poznan University of Physical EducationCompletedEndothelial DysfunctionPoland
Clinical Trials on Beet It Sport Shot
-
University of ManitobaCompleted
-
Newcastle UniversityUniversity of Nottingham; Liverpool John Moores University; University of the... and other collaboratorsCompletedBlood PressureUnited Kingdom
-
University Hospital, GhentResearch Foundation FlandersRecruiting
-
Brooke Army Medical CenterCompletedSystolic Heart Failure
-
Royal Surrey County Hospital NHS Foundation TrustUnknownColorectal Cancer
-
Southern Methodist UniversityCompleted
-
Western Sydney Local Health DistrictWestmead Institute for Medical ResearchCompletedHypertension | Endothelial Dysfunction | Autosomal Dominant Polycystic KidneyAustralia
-
Penn State UniversityCompleted
-
Penn State UniversityCompletedPostmenopausal WomenUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedPeripheral Arterial DiseaseUnited States